Skip to content

SAUKAMED

Active
Private limited companyfounded 20188 yrs activeOlivetenvest 40, 2800 Mechelen, BelgiumKBO/BCE: BE 0696.839.486

SAUKAMED has been active since 2018 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €297k and a net result of €79k. Equity is growing by ~25.3% per year across the filed fiscal years. Its solvency ranks better than 42% of 16193 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).

Checked score

Score 2025
85 / 100
Excellent▼ -8 vs 2024
The score combines four axes. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability100▲+28
Solvency76▼-24
Growth78=
Stability100
Bankruptcy probability, 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €25k at 30 days acceptable
Liquidity tight (current ratio 1.05 against 3.86 in 2024), and 45.8% of the assets are financed with debt.
Credit advice for your own amount and term

Signals

Six signals. The signal on the left, the evidence on the right.
lowers risk+raises riskneutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
54.2%
Return on assets
14.5%
Age of the figures
8 mo
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation date
Age against the risk zone
elevated failure risk from 2 to 8 years 8 years 0 10 y
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 06-08-2026, 6 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 8 filings
Deviation from the deadline
2025
6 d late
2024
6 d late
2023
29 d late
2022
28 d late
2021
on the day
2020
31 d late
2019
28 d early
← before the deadline after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
07-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2025, micro schema

Equity
€297k▼ 53.2%
2024 · €633k
2018: €88k 2019: €192k 2020: €287k 2021: €389k 2022: €434k 2023: €542k 2024: €633k
2018 → 2025
Total assets
€547k▼ 37.5%
2024 · €876k
2018: €584k 2019: €626k 2020: €691k 2021: €767k 2022: €764k 2023: €873k 2024: €876k
2018 → 2025
Net result
€79k▼ 12.9%
2024 · €91k
2018: €75k 2019: €104k 2020: €95k 2021: €102k 2022: €46k 2023: €147k 2024: €91k
2018 → 2025
Working capital
€9k▼ 97.3%
2024 · €338k
2018: €-329k 2019: €188k 2020: €281k 2021: €208k 2022: €184k 2023: €284k 2024: €338k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise ▼ fall
Line20212022202320242025Trend
Equity€389k-€434k▲ 11.7%€542k▲ 24.8%€633k▲ 16.8%€297k▼ 53.2%
Operating result€148k-€61k▼ 58.4%€198k▲ 222%€119k▼ 39.9%€104k▼ 13.1%
Net result€102k-€46k▼ 55.3%€147k▲ 223%€91k▼ 38.0%€79k▼ 12.9%
Turnover and EBIT margin not published: the abbreviated or micro schema does not require them.
Result per fiscal year
Operating resultNet result
€0€50k€100k€150k€200kOperating result 2021: €148k€148kNet result 2021: €102k€102kOperating result 2022: €61k€61kNet result 2022: €46k€46kOperating result 2023: €198k€198kNet result 2023: €147k€147kOperating result 2024: €119k€119kNet result 2024: €91k€91kOperating result 2025: €104k€104kNet result 2025: €79k€79k20212022202320242025
The operating result has fallen two years in a row; 2025 is 13% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €547k
Fixed assets €359k▼ 14.5%
Current assets €188k▼ 58.7%
Equity and liabilities €547k
Equity €297k▼ 53.2%
Debt €251k▲ 3.4%
The debt ratio rises from 27.7% to 45.8%: debt grows while equity shrinks.
Key figures and ratios
2025 value · change against 2024
EBITDA
€177k
2024 · €189k
Cash flow
€153k
2024 · €161k
Solvency
54.2%
2024 · 72.3%
Current ratio
1.05
2024 · 3.86
Quick ratio
1.05
2024 · 3.86
Debt / equity
0.85
2024 · 0.38
ROE
26.8%
2024 · 14.4%
ROA
14.5%
2024 · 10.4%
Interest coverage
91.73
2024 · 73.19
Debt
€251k
2024 · €242k
Debt ≤ 1 year
€179k
2024 · €118k
Debt > 1 year
€72k
2024 · €125k
Income taxes
€22k
2024 · €25k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet Code20242025
Assets
Total assets20/58€876k€547k
Fixed assets21/28€420k€359k
Intangible fixed assets21€135k€90k
Tangible fixed assets22/27€285k€269k
Land and buildings22€135k€123k
Plant, machinery and equipment23€145k€135k
Furniture and vehicles24€6k€11k
Current assets29/58€455k€188k
Amounts receivable within one year40/41€21k€25k
Trade receivables40€5k€7k
Other amounts receivable41€17k€18k
Cash at bank and in hand54/58€393k€129k
Deferred charges and accrued income490/1€42k€35k
Equity and liabilities
Total equity and liabilities10/49€876k€547k
Equity10/15€633k€297k
Contributions10/11€20k€20k=
Reserves13€613k€276k
Distributable reserves133€613k€276k
Amounts payable17/49€242k€251k
Amounts payable after more than one year17€125k€72k
Financial debts170/4€116k€65k
Other amounts payable178/9€8k€7k
Amounts payable within one year42/48€118k€179k
Current portion of amounts payable after more than one year42€51k€51k
Trade debts44€19k€80
Suppliers440/4€19k€80
Taxes, remuneration and social security45€6k€6k
Taxes450/3-€183
Remuneration and social security454/9€6k€6k
Other amounts payable47/48€43k€121k
Income statement Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€70k€73k
Other operating charges640/8€1k€1k
Gross operating margin9900€190k€178k
Operating profit (loss)9901€119k€104k
Financial income75/76B€0€1
Recurring financial income75€0€1
Financial charges65/66B€3k€2k
Recurring financial charges65€3k€2k
Profit (loss) for the period before taxes9903€117k€102k
Income taxes67/77€25k€22k
Profit (loss) for the period9904€91k€79k
Profit (loss) for the period to be appropriated9905€91k€79k
Appropriation of the result
Profit (loss) to be appropriated9906€91k€79k
Transfer from equity791/2-€416k
Transfer to equity691/2€91k€79k
To other reserves6921€91k€79k
Profit to be distributed694/7-€416k
Return on contributions (dividend)694-€416k

The notes to these accounts (9 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
06-08
NBB filing Annual accounts filed
fiscal year 2025 · micro schema · 6 days late
2025
06-08
NBB filing Annual accounts filed
fiscal year 2024 · micro schema · 6 days late
2024
29-08
NBB filing Annual accounts filed
fiscal year 2023 · micro schema · 29 days late
2023
31-12
Financial Highest result since 2018net €147k ▲223%
Operating result €198k, net result €147k, both a record.
31-12
Financial Equity above €500kEq €542k ▲24.8%
6 profitable years in a row build equity to €542k.
28-08
NBB filing Annual accounts filed
fiscal year 2022 · micro schema · 28 days late
2022
31-12
Financial Weakest financial yearnet €46k ▼55.3%
Net result drops to €46k, the lowest in the series; recovery starts the following year.
31-07
NBB filing Annual accounts filed
fiscal year 2021 · micro schema
2021
31-08
NBB filing Annual accounts filed
fiscal year 2020 · abbreviated schema · 31 days late
2020
31-12
Financial Equity above €200kEq €287k ▲49.3%
3 profitable years in a row build equity to €287k.
03-07
NBB filing Annual accounts filed
fiscal year 2019 · abbreviated schema
2019
31-12
Financial Liquidity times 12current ratio 3.88
Current ratio from 0.33 to 3.88; short-term debt falls from €493k to €65k.
31-12
Financial Equity above €150kEq €192k ▲119%
2 profitable years in a row build equity to €192k.
25-07
NBB filing Annual accounts filed
fiscal year 2018 · abbreviated schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

Directors · office · real estate

Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Mechelen · 1 establishment unit since 2018
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Olivetenvest 402800 Mechelen
Ground area
620 m²
Building footprint
160 m²
Volume, LiDAR
1,568 m³
Parcel 12404F0059/00G005, Flanders · tallest building 15.5 m, ±4 floors. Linked by address, not a title deed.
1 establishment unit
DR. KATRINE SAUER
Olivetenvest 40, 2800 MechelenSpecialist medical practice
since 20182.276.043.830
1 parcel
Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
12404F0059/00G005 Flanders 620 m² 1 · 160 m² 15.5 m · 4 fl.
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Similar companies · same sector, comparable size

Of 16,587 companies in sector 86220 we hold annual accounts for 7,941. 6,639 are within a factor 10 of this equity.See the whole sector

Company data · Crossroads Bank

Identification
Legal formPrivate limited company
Founded28-05-2018
Fiscal year end31-12
Activities, NACEBEL
86220Specialist medical practice
82990Other business support services
Sources
Crossroads Bank for EnterprisesNational Bank · 8 filingsAddress and cadastre registers

Data from official sources, last processed on 07-09-2026. Scores and ratios are computed by Checked and are not a credit decision.